期刊文献+
共找到5篇文章
< 1 >
每页显示 20 50 100
奥美拉唑及胶体果胶铋四联疗法根除幽门螺杆菌感染的研究 被引量:3
1
作者 曲年聪 孙丽萍 《系统医学》 2020年第15期35-37,共3页
目的探讨和研究奥美拉唑及胶体果胶铋四联疗法根除幽门螺杆菌感染的临床效果。方法选取2017年3月—2019年11月烟台龙矿中心医院接诊治疗的66例幽门螺杆菌感染患者,将其按照随机数字表格的方式进行分组,即A组(n=22,奥美拉唑+胶体果胶铋+... 目的探讨和研究奥美拉唑及胶体果胶铋四联疗法根除幽门螺杆菌感染的临床效果。方法选取2017年3月—2019年11月烟台龙矿中心医院接诊治疗的66例幽门螺杆菌感染患者,将其按照随机数字表格的方式进行分组,即A组(n=22,奥美拉唑+胶体果胶铋+阿莫西林+克拉霉素四联疗法治疗)、B组(n=22,奥美拉唑+阿莫西林+克拉霉素三联疗法治疗)、C组(n=22,胶体果胶铋+阿莫西林+克拉霉素三联疗法治疗),对比3组幽门螺杆菌感染患者最终的治疗效果。结果A组患者的幽门螺杆菌根除率与B组患者相比较,明显较高(χ^2=4.660,P=0.030);同时,A组患者的幽门螺杆菌根除率显著高于C组,差异有统计学意义(χ^2=5.940,P=0.010);3组患者在药物治疗期间的不良反应发生率分别为4.55%、27.27%、27.27%,相比较来说,A组患者明显低于B组和C组(χ^2=4.250,P=0.040;χ^2=4.250,P=0.040)。结论在对幽门螺杆菌感染患者进行治疗的过程中,可以采用奥美拉唑及胶体果胶铋四联疗法的方式,能够在一定程度上较好地提升临床治疗的效果。 展开更多
关键词 幽门螺杆菌感染患者 奥美拉唑 胶体果胶铋 四联疗法 治疗效果
下载PDF
根治消化性溃疡幽门螺杆菌感染(HP)中实施远程护理干预的效果
2
作者 黄艳华 朱小蓓 +1 位作者 陈峥 王慧英 《中文科技期刊数据库(引文版)医药卫生》 2021年第10期267-269,共3页
探究远程护理干预模式应用在根治消化性溃疡幽门螺杆菌感染(HP)患者护理中的应用效果。方法:纳入本次研究的对象共计70例,均为本院接诊的消化性溃疡幽门螺杆菌感染(HP)患者,纳入本次研究的时间区间为2020年1月起到2021年1月止,分组依据... 探究远程护理干预模式应用在根治消化性溃疡幽门螺杆菌感染(HP)患者护理中的应用效果。方法:纳入本次研究的对象共计70例,均为本院接诊的消化性溃疡幽门螺杆菌感染(HP)患者,纳入本次研究的时间区间为2020年1月起到2021年1月止,分组依据为随机数字表法,患者被平均纳入至实验组(35例,接受远程护理干预模式)和参照组(35例,接受常规护理干预)。针对二者护理前后生活质量评分、HP清除率、护理满意度情况展开比较。结果:护理后对生活质量评分进行比较,结果为实验组均优于参照组,差异具有统计学意义(p<0.05);针对二者护理满意度进行比较,结果为实验组患者94.29%明显较参照组71.43%更高,数据差异存在统计学意义(p<0.05);针对二者HP清除率进行比较,结果为实验组患者94.29%明显较参照组60.00%更高,数据差异存在统计学意义(p<0.05)。结论:将远程护理干预模式应用到消化性溃疡幽门螺杆菌感染(HP)患者的临床护理中,明显提高HP清除率,对于生活质量的提高有着积极作用,具有一定的可行性,在临床中值得推广以及应用。 展开更多
关键词 消化性溃疡幽门杆菌感染(HP)患者 远程护理干预模式 HP清除率
下载PDF
Influence of H pylori on plasma ghrelin in patients without atrophic gastritis 被引量:14
3
作者 Mehmet Cindoruk Ilhan Yetkin +3 位作者 Serpil Muge Deger Tarkan Karakan Erdal Kan Selahattin Unal 《World Journal of Gastroenterology》 SCIE CAS CSCD 2007年第10期1595-1598,共4页
AIM:To determine the association between H pylori infection and serum ghrelin levels in patients without atrophic gastritis.METHODS:Fifty consecutive patients(24 males and 26 females)with either H pylori-positive gast... AIM:To determine the association between H pylori infection and serum ghrelin levels in patients without atrophic gastritis.METHODS:Fifty consecutive patients(24 males and 26 females)with either H pylori-positive gastritis(n = 34)or H pylori-negative gastritis(n = 16)with normal gastric acid secretion determined by 24-h pHmetry and without atrophic gastritis in histopathology were enrolled in this study.Thirty-four H pylori-infected patients were treated with triple therapy consisting of a daily regimen of 30 mg lansoprazole bid,1 g amoxicillin bid and 500 mg clarithromycin bid for 14 d,followed by an additional 4 wk of 30 mg lansoprazol treatment.H pylori infection was eradicated in 23 of 34(67.6%)patients.H pylori-positive patients were given eradication therapy.Gastric acidity was determined via intragastric pH catethers.Serum ghrelin was measured by radioimmunoassay(RIA).RESULTS:There was no signifficant difference in plasma ghrelin levels between H pylori-positive and H pylori-negative groups(81.10 ± 162.66 ng/L vs 76.51 ± 122.94 ng/L).In addition,there was no significant difference in plasma ghrelin levels and gastric acidity levels measured before and 3 mo after the eradication therapy.CONCLUSION:H pylori infection does not influence ghrelin secretion in patients with chronic gastritis without atrophic gastritis. 展开更多
关键词 H pylori GHRELIN Gastric acidity Gtrophic gastritis
下载PDF
H pylori seroprevalence in patients with lung cancer 被引量:7
4
作者 Katayoon Najafizadeh Sayeed Falah Tafti +2 位作者 Masoud Shiehmorteza Masoud Saloor Masoud Jamali 《World Journal of Gastroenterology》 SCIE CAS CSCD 2007年第16期2349-2351,共3页
AIM: To assess H pylori seroprevalence in lung cancer and determine whether there is a potential association between lung cancer and H pylori infection. METHODS: The study was conducted on forty consecutive patients w... AIM: To assess H pylori seroprevalence in lung cancer and determine whether there is a potential association between lung cancer and H pylori infection. METHODS: The study was conducted on forty consecutive patients with lung cancer, confirmed by pathology (32 men, 8 women; mean age 55.50 ± 11.91 years, range 16-77 years). Forty healthy subjects (25 men, 15 women; mean age 43.08 ± 12.60 years, range 20-79 years) from the patients’ family members were matched to each case subject on the basis of age and socioeconomic status. H pylori infection was detected with a commercially available immunoglobulin G (IgG) enzyme-linked immunosorbent assay (Trinity kit, Biotech co., USA), previously validated in adults (86% sensitivity, 96% specificity) against a gold standard of culture and histology. RESULTS: H pylori seropositivity was present in 52.5% of patients with lung cancer in comparison to 45.0% of healthy control subjects. Although H pylori seropositivity was more frequent in lung cancer patients than in controls, the difference did not reach statistical significance (OR = 1.35, 95% CI = 0.56-3.25; P = 0.65). In addition, there was no significant difference between cases and controls in terms of gastrointestinal symptoms. CONCLUSION: The earlier described association between H pylori infection and lung cancer was not supported in this study. Further studies with larger sample sizes should be undertaken to assess the frequency of H pylori infection in patients with lung cancer and their potential association. 展开更多
关键词 Lung neoplasm H pylori Helicobacter infections/complications Carcinoma/Non-small cell Carcinoma/Squamous cell Case-control studies
下载PDF
Helicobacter pylori infection in bleeding peptic ulcer patients after non-steroidal antiinflammatory drug consumption 被引量:4
5
作者 Francesco Manguso Elisabetta Riccio +8 位作者 Germana de Nucci Maria Luisa Aiezza Gerardino Amato Linda Degl'Innocenti Maria Maddalena Piccirillo Gianfranco De Dominicis Tara Santoro Elena Trimarco Antonio Balzano 《World Journal of Gastroenterology》 SCIE CAS CSCD 2011年第40期4509-4516,共8页
AIM: TO establish the prevalence of He/icobacterpy/on (H. pylori) infection in patients with a bleeding peptic ulcer after consumption of non-steroidal antiinflammatory drugs (NSAIDs).METHODS: A very early upper... AIM: TO establish the prevalence of He/icobacterpy/on (H. pylori) infection in patients with a bleeding peptic ulcer after consumption of non-steroidal antiinflammatory drugs (NSAIDs).METHODS: A very early upper endoscopy was performed to find the source of upper gastrointestinal bleeding and to take biopsy specimens for analysis of H. pylori infection by the rapid urease (CLO) test, his- tological examination, and bacterial culture. TgG anti- CagA were also sought. The gold standard for identifying H. pylori infection was positive culture of biopsy specimens or contemporary positivity of the CLO test and the presence of H. pylori on tissue sections.RESULTS: Eighty patients, 61 males (76.3%), mean age 61.2 ~ 15.9 years, were consecutively enrolled. Forty-seven (58.8%) patients occasionally consumed NSAIDs, while 33 (41.3%) were on chronic treatment with low-dose aspirin (LD ASA). Forty-four (55.0%) patients were considered infected by H. pylori. The infection rate was not different between patients who occasionally or chronically consumed NSAIDs. The culture of biopsy specimens had a sensitivity of 86.4% and a specificity of 100%; corresponding figures for histological analysis were 65.9% and 77.8%, for the CLO test were 68.2% and 75%, for the combined use of histology and the CLO test were 56.8% and 100%, and for IgG anti-CagA were 90% and 98%. The high- est accuracy (92.5%) was obtained with the culture of biopsy specimens.CONCLUSION: Patients with a bleeding peptic ulcer after NSAID/LD ASA consumption frequently have H. pylori infection. Biopsy specimen culture after an early upper gastrointestinal tract endoscopy seems the most efficient test to detect this infection. 展开更多
关键词 Helicobacter pylori Helicobacter pylori in-fection Low-dose aspirin Non-steroidal antiinflamma-tory drugs Peptic ulcer hemorrhage ENDOSCOPY
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部